Medlive is proud to share that our abstract has been accepted for presentation at the upcoming American College of Rheumatology (ACR) Convergence 2025, taking place October 24–29, 2025, in Chicago, IL.
Poster Title: Addressing Hesitancy in JAK Inhibitor Use: Outcomes from Continuing Medical Education Reveal Confidence-Knowledge Gaps Among Community Rheumatologists
Submission Number: 2129700
Session: Poster Session C (2159–2194), Professional Education Poster
Date: Tuesday, October 28, 2025
Time: 10:30 AM – 12:30 PM CT
Presenter: Carole Drexel
Developed in collaboration with AiArthritis, this poster highlights findings from educational initiatives that integrate both clinician and patient perspectives. The research underscores how CME participation influences awareness, confidence, and clinical readiness among community rheumatologists in prescribing JAK inhibitors, while emphasizing the value of integrating the patient experience into education that informs care.
“At AiArthritis, we like to say that ‘We don’t represent the patient voice, we are the patient voice.’ We’re proud to partner with Medlive to advance this mission, ensuring that the patient voice is integrated into education that informs rheumatologists and care teams, empowering providers to deliver care that is both evidence-based and deeply person-centered.”
— AiArthritis
This collaboration exemplifies how partnerships between patient advocacy organizations and medical education innovators can strengthen the connection between evidence and empathy, supporting better outcomes for patients and providers alike.
To learn more about collaborating with Medlive to develop impactful CME programs in rheumatology and other therapeutic areas, visit our Contact Us page to connect with our team.
